Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Patient Voice In New Zealand Trials Encouraged But Not Mandatory, Medsafe Says
Jan 20 2026
•
By
Vibha Sharma
Sponsors with strong pharmacovigilance systems can be exempted from expedited SUSAR reporting
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Clinical Trials
More from R&D